Pleiotropic effects of human papillomavirus type 16 E6 oncogene expression in human epithelial cell lines

Journal of General Virology

Volumn 80, Issue 7, 1999, Pages 1707-1713

  Mythily, D Viji ^a,b   Krishna, Sudhir ^a   Tergaonkar, Vinay ^a  

^a UNIVERSITY OF AGRICULTURAL SCIENCES   (India)

^b WELLCOME CRC INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0033029836     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-7-1707     Document Type: Article

References (44)

1. Brown, J., Higo, H., McKalip, A. & Herman, B. (1997). Human papillomavirus (HPV) 16 E6 sensitizes cells to atractyloside-induced apoptosis: role of p53, ICE-like proteases and the mitochondrial permeability transition. Journal of Cellular Biochemistry 66, 245-255.
2. Charvat, S., Chignol, M. C., Souchier, C., Le Griel, C., Schmitt, D. & Serres, M. (1998). Cell migration and MMP-9 secretion are increased by epidermal growth factor in HaCaT-ras transfected cells. Experimental Dermatology 7, 184-190.
3. Chen, J. J., Reid, C. E., Band, V. & Androphy, E. J. (1995). Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269, 529-531.
4. Crook, T., Wrede, D. & Vousden, K. H. (1991). p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6, 873-875.
5. Daniel, B., Rangarajan, A., Mukherjee, G., Vallikad, E. & Krishna, S. (1997). The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. Journal of General Virology 78, 1095-1101.
6. Desantes, C., Hallez, S., Alphen, P. V. & Burny, A. (1992). Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. Journal of Virology 66, 325-333.
7. Dey, A., Atcha, I. A. & Bagchi, S. (1997). HPV 16 E6 oncoprotein stimulates the transforming growth factor-beta 1 promoter in fibroblasts through a specific GC-rich sequence. Virology 228, 190-199.
8. Etscheid, B. G., Foster, S. A. & Galloway, D. A. (1994). The E6 protein of human papillomavirus type 16 functions as a transcriptional repressor in a mechanism independent of the tumor suppresser protein, p53. Virology 205, 583-585.
9. Faraldo, M. M., Deugnier, M. A., Lukashev, M., Thierry, J. P. & Glukhova, M. A. (1998). Perturbation of beta1-integrin function alters the development of murine mammary gland. EMBO Journal 17, 2139-2147.
10. Fishman, R. B. & Hatten, M. E. (1993). Multiple receptor systems promote CNS neural migration. Journal of Neuroscience 13, 3485-3495.
11. Hanahan, D. & Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell 86, 353-364.
12. Harlow, E. & Lane, D. (1988). Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
13. Juliano, R. L. (1993). The role of β1 integrins in tumors. Seminars in Cancer Biology 4, 277-283.
14. Keely, P. J., Westwick, J. K., Whitehead, I. A., Der, J. C. & Parise, L. V. (1997). Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 390, 632-636.
15. Keely, P., Parise, L. & Juliano, R. (1998). Integrins and GTPases in tumour cell growth, motility and invasion. Trends in Cell Biology 8, 101-106.
16. Kinoshita, T., Shirasawa, H., Shino, Y., Moriya, H., Desbarats, L., Eilers, M. & Simizu, B. (1997). Transactivation of prothymosin a and c-myc promoters by human papillomavirus type 16 E6 protein. Virology 232, 53-61.
17. Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T. & Ishibashi, M. (1997). Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proceedings of the National Academy of Sciences, USA 94, 11612-11616.
18. Lee, S. S., Weiss, R. S. & Javier, R. T. (1997). Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proceedings of the National Academy of Sciences, USA 94, 6670-6675.
19. Lehman, T. A., Modali, R., Boukamp, P., Stanek, J., Bennett, W. P., Welsh, J. A., Metcalf, R. A., Stampfer, M. R., Fusenig, N. & Rogan, E. M. (1993). p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14, 833-839.
20. Matter, M. L., Zhang, Z., Nordstedt, C. & Ruoslahti, E. (1998). The alpha5beta1 integrin mediates elimination of amyloid-beta peptide and protects against apoptosis. Journal of Cell Biology 141, 1019-1030.
21. Meredith, J. E. & Schwartz, M. A. (1997). Integrins, adhesion and apoptosis. Trends in Cell Biology 78, 146-150.
22. Pan, H. & Griep, A. E. (1995). Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes & Development 9, 2157-2169.
23. Rapp, L. & Chen, J. J. (1998). The papillomavirus E6 proteins. Biochimica et Biophysica Acta 1378, F1-19.
24. Rozzo, C., Chiesa, V., Caridi, G., Pagnan, G. & Ponzoni, M. (1997). Induction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesion. International Journal of Cancer 70, 688-698.
25. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
26. Scatena, M., Almeida, M., Chaisson, M. L., Fausto, N., Nicosia, R. F. & Giachelli, C. M. (1998). NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. Journal of Cell Biology 141, 1083-1093.
27. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.
28. Schwartz, M. A. (1997). Integrins, oncogenes and anchorage independence. Journal of Cell Biology 139, 575-578.
29. Sheetz, M. P., Felsenfeld, D. P. & Galbraith, C. G. (1998). Cell migration: regulation of force on extracellular-matrix-integrin complexes. Trends in Cell Biology 8, 51-54.
30. Sherman, L. & Schlegel, R. (1996). Serum and calcium induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papilloma virus type 16. Journal of Virology 70, 3269-3279.
31. Shirasawa, H., Jin, M. H., Shimizu, K., Akutsu, N., Shino, Y. & Simizu, B. (1994). Transcription-modulatory activity of full-length E6 and E6*I proteins of human papillomavirus type 16. Virology 203, 36-42.
32. Skobe, M., Rockwell, P., Goldstein, N., Vosseler, S. & Fusenig, N. E. (1997). Halting angiogenesis suppresses carcinoma cell invasion. Nature Medicine 3, 1222-1227.
33. Steller, M. A., Zou, Z., Schiller, J. T. & Baserga, R. (1996). Transformation by human papillomavirus 16 E6 and E7: role of the insulin-like growth factor 1 receptor. Cancer Research 56, 5087-5091.
34. Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardil, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G. & Banks, L. (1998). Role of p53 polymorphism in the development of human-papillomavirus-associated cancer. Nature 393, 229-234.
35. Tergaonkar, V., Mythily, D. V. & Krishna, S. (1997). Cytokeratin patterns of expression in human epithelial cell lines correlate with transcriptional activity of the human papillomavirus type 16 upstream regulatory region. Journal of General Virology 78, 2601-2606.
36. Thomas, M., Matlashewski, G., Pim, D. & Banks, L. (1996). Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation. Oncogene 13, 265-273.
37. Tong, X. & Howley, P. M. (1997). The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proceedings of the National Academy of Sciences, USA 94, 4412-4417.
38. Tong, X., Boll, W., Kirchhausen, T. & Howley, P. M. (1998). Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1. Journal of Virology 72, 476-482.
39. Vande Pol, S. B., Brown, M. C. & Turner, C. E. (1998). Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene 16, 43-52.
40. Wahl, A. F., Donaldson, K. L., Fairchild, C., Lee, F. Y., Foster, S. A., Demers, G. W. & Galloway, D. A. (1996). Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis. Nature Medicine 2, 72-79.
41. Werness, B. A., Levine, A. J. & Howley, P. M. (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248, 76-79.
42. Xu, C., Meikrantz, W., Schlegel, R. & Sager, R. (1995). The human papilloma virus 16 E6 gene sensitizes human mammary epithelial cells to apoptosis induced by DNA damage. Proceedings of the National Academy of Sciences, USA 92, 7829-7833.
43. Yu, Y., Li, C. Y. & Little, J. B. (1997). Abrogation of p53 function by HPV 16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells. Oncogene 14, 1661-1667.
44. zur Hausen, H. (1996). Papillomavirus infections - a major cause of human cancers. Biochimica et Biophysica Acta 1288, 55-78.